Publicacións en colaboración con investigadores/as de Durham University (3)

2022

  1. Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme

    United European gastroenterology journal, Vol. 10, Núm. 3, pp. 330-343

2020

  1. Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis

    Gastroenterology, Vol. 159, Núm. 5, pp. 1672-1685.e5

2019

  1. Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

    Gastroenterology, Vol. 157, Núm. 1, pp. 74-86.e15